Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer

被引:0
|
作者
Xin, Shuyue [1 ]
Wen, Shuang [2 ]
He, Peipei [1 ]
Zhao, Yulong [1 ]
Zhao, Hui [1 ]
机构
[1] Dalian Med Univ, Dept Hlth Examinat Ctr, Affiliated Hosp 2, Dalian, Peoples R China
[2] Friendship Hosp Dalian, Dept Pathol, Dalian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
tertiary lymphoid structures (TLS); non-small cell lung cancer (NSCLC); prognosis; tumor immune microenvironment (TIME); nomogram; RELEVANCE; CD47;
D O I
10.3389/fimmu.2024.1423775
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Tertiary lymphoid structures (TLS), ordered structure of tumor-infiltrating immune cells in tumor immune microenvironment (TIME), play an important role in the development and anti-tumor immunity of various cancers, including liver, colon, and gastric cancers. Previous studies have demonstrated that the presence of TLS in intra-tumoral (IT), invasive margin (IM), and peri-tumoral (PT) regions of the tumors at various maturity statuses. However, the density of TLS in different regions of non-small cell lung cancer (NSCLC) has not been extensively studied.Methods TLS and tumor-infiltrating immune cells were assessed using immunohistochemistry (IHC) staining in 82 NSCLC patients. Tumor samples were divided into three subregions as IT, IM and PT regions, and TLS were identified as early/primary TLS (E-TLS) or secondary/follicular TLS (F-TLS). The distribution of TLS in different maturity statuses, along with their correlation with clinicopathological characteristics and prognostic value, was assessed. Nomograms were used to predict the probability of 1-, 3-, and 5-year overall survival (OS) in patients with NSCLC.Results The density of TLS and proportion of F-TLS in the IT region (90.2%, 0.45/mm2, and 61.0%, respectively) were significantly higher than those in the IM region (72.0%, 0.18/mm2, and 39.0%, respectively) and PT region (67.1%, 0.16/mm2, and 40.2%, respectively). A lower density of TLS, especially E-TLS in the IM region, was correlated with better prognosis in NSCLC patients. CD20+ B cells, CD3+ T cells, CD8+ cytotoxic T cells, and CD68+ macrophages were significantly overexpressed in the IM region. CD20+ B cells and CD3+ T cells in the IM region were significantly correlated with the density of E-TLS, while no statistically significant correlation was found with F-TLS. The E-TLS density in the IM region and TNM stage were independent prognostic factors for NSCLC patients. The nomogram showed good prognostic ability.Conclusions A higher density of E-TLS in the IM region was associated with a worse prognosis in NSCLC patients, potentially due to the inhibition of TLS maturation caused by the increased density of suppressive immune cells at the tumor invasion front.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
    Song, Peng
    Yang, Dongliang
    Cui, Xiaoxia
    Wang, Hanping
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5975 - 5985
  • [42] The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
    Charpidou, Andriani
    Fevranoglou, Christina
    Sotirios, Tsimpoukis
    Paraskevi, Boura
    Zontanos, Marios
    Danos, Ioannis
    Syrigos, Konstantinos
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [43] Effect of delays on prognosis in patients with non-small cell lung cancer
    Myrdal, G
    Lambe, M
    Hillerdal, G
    Lamberg, K
    Agustsson, T
    Ståhle, E
    [J]. THORAX, 2004, 59 (01) : 45 - 49
  • [44] Prognosis of Non-small cell lung cancer in relation to the smoking status in a tertiary care Hospital, Karachi, Pakistan
    Khan, Nehad
    Bari, Muhammad Furqan
    Abbas, Farah Fatima
    Farooqui, Waqas Ahmed
    Shabbir, Asma
    Razzaq, Abdul
    [J]. RAWAL MEDICAL JOURNAL, 2024, 49 (02): : 302 - 305
  • [45] Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer
    Perez, EA
    [J]. CHEST, 1998, 114 (02) : 593 - 604
  • [46] Tertiary lymphoid structures and gastric cancer prognosis
    Kemi, Niko
    Ylitalo, Olli
    Vayrynen, Juha P.
    Helminen, Olli
    Junttila, Anna
    Mrena, Johanna
    Bohm, Jan
    Kauppila, Joonas H.
    [J]. APMIS, 2023, 131 (01) : 19 - 25
  • [47] Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
    Mehrdad Rakaee
    Thomas K. Kilvaer
    Simin Jamaly
    Thomas Berg
    Erna-Elise Paulsen
    Marte Berglund
    Elin Richardsen
    Sigve Andersen
    Samer Al-Saad
    Mette Poehl
    Francesco Pezzella
    David J. Kwiatkowski
    Roy M. Bremnes
    Lill-Tove Rasmussen Busund
    Tom Donnem
    [J]. British Journal of Cancer, 2021, 124 : 1680 - 1689
  • [48] Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
    Rakaee, Mehrdad
    Kilvaer, Thomas K.
    Jamaly, Simin
    Berg, Thomas
    Paulsen, Erna-Elise
    Berglund, Marte
    Richardsen, Elin
    Andersen, Sigve
    Al-Saad, Samer
    Poehl, Mette
    Pezzella, Francesco
    Kwiatkowski, David J.
    Bremnes, Roy M.
    Busund, Lill-Tove Rasmussen
    Donnem, Tom
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (10) : 1680 - 1689
  • [49] Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer
    Bessede, Alban
    Peyraud, Florent
    Le Moulec, Sylvestre
    Cousin, Sophie
    Cabart, Mathilde
    Chomy, Francois
    Rey, Christophe
    Lara, Oren
    Odin, Ophelie
    Nafia, Imane
    Guegan, Jean-Philippe
    Italiano, Antoine
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (23) : 4883 - 4893
  • [50] FDG-uptake of non-small cell lung cancer: Correlation with cell proliferation and cellular density.
    Higashi, K
    Seki, H
    Ueda, Y
    Ayabe, K
    Motomura, Y
    Wan, G
    Taniguchi, M
    Oguchi, M
    Okimura, T
    Yamamoto, I
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 247P - 248P